Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Claude Tardy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
AIDS Reviews|July 25, 2003
Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a reviewAlain Lafeuillade, Jean-Claude Tardy
Comptes Rendus Biologies|August 7, 2010
HIV-1 infection: functional competition between gp41 and interleukin-2Kamel Sanhadji, Jean-Claude Tardy, Jean-Louis Touraine
Journal of Medical Virology|June 8, 2017
Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samplesMary-Anne Trabaud, Vinca Icard, Christophe Ramière, et al.
Retrovirology|June 6, 2007
Human Polycomb group EED protein negatively affects HIV-1 assembly and releaseDina Rakotobe, Jean-Claude Tardy, Patrice André, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Depletion in antibodies targeted to the HR2 region of HIV-1 glycoprotein gp41 in sera of HIV-1-seropositive patients treated with T20Nadine Vincent, Jean-Claude Tardy, Jean-Michel Livrozet, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2016
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?Vincent Calvez, Laurent Hocqueloux, Jean-Luc Meynard, et al.
Infectious Diseases and Therapy|March 25, 2026
Role of Community Associations in HIV, HBV and HCV Screening and Support for Migrant Populations in France: Results of the DéPAC StudyDulce Alfaiate, Jean-Claude Tardy, Caroline Andoum, et al.
Journal of Medical Virology|February 25, 2009
Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithmsLaurent Cotte, Mary-Anne Trabaud, Jean-Claude Tardy, et al.
Cytometry. Part B, Clinical Cytometry|September 29, 2012
CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjectsJulien Saison, Julie Demaret, Fabienne Venet, et al.
AIDS Research and Human Retroviruses|October 22, 2014
Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientMary-Anne Trabaud, Laurent Cotte, Julien Saison, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
AIDS Reviews|July 25, 2003
Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a reviewAlain Lafeuillade, Jean-Claude Tardy
Comptes Rendus Biologies|August 7, 2010
HIV-1 infection: functional competition between gp41 and interleukin-2Kamel Sanhadji, Jean-Claude Tardy, Jean-Louis Touraine
Journal of Medical Virology|June 8, 2017
Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samplesMary-Anne Trabaud, Vinca Icard, Christophe Ramière, et al.
Retrovirology|June 6, 2007
Human Polycomb group EED protein negatively affects HIV-1 assembly and releaseDina Rakotobe, Jean-Claude Tardy, Patrice André, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Depletion in antibodies targeted to the HR2 region of HIV-1 glycoprotein gp41 in sera of HIV-1-seropositive patients treated with T20Nadine Vincent, Jean-Claude Tardy, Jean-Michel Livrozet, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2016
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?Vincent Calvez, Laurent Hocqueloux, Jean-Luc Meynard, et al.
Infectious Diseases and Therapy|March 25, 2026
Role of Community Associations in HIV, HBV and HCV Screening and Support for Migrant Populations in France: Results of the DéPAC StudyDulce Alfaiate, Jean-Claude Tardy, Caroline Andoum, et al.
Journal of Medical Virology|February 25, 2009
Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithmsLaurent Cotte, Mary-Anne Trabaud, Jean-Claude Tardy, et al.
Cytometry. Part B, Clinical Cytometry|September 29, 2012
CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjectsJulien Saison, Julie Demaret, Fabienne Venet, et al.
AIDS Research and Human Retroviruses|October 22, 2014
Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientMary-Anne Trabaud, Laurent Cotte, Julien Saison, et al.
Pageof 2